Menu
MENU
Sign In   
Search
Sign In        
Home   >   Products
leiter-international-performance-scale

Cognistat

Ralph J. Kiernan, PhD, Jonathan Mueller, MD, and J. William Langston, MD

Purpose:
Assesses neurocognitive functioning
Format:
Paper and pencil
Age range:
12 years and older
Time:
10 minutes for cognitively intact clients; 20–30 minutes for cognitively impaired clients
Qualification level:
S
S
A degree, certificate, or license to practice in a health care profession or occupation, including (but not limited to) the following: medicine, neurology, nursing, occupational therapy and other allied health care professions, physician's assistants, psychiatry, social work; plus appropriate training and experience in the ethical administration, scoring, and interpretation of clinical behavioral assessment instruments. Certain health care providers may be eligible to purchase selected "B" and "C" level instruments within their area of expertise. Specifically, relevant supervised clinical experience using tests (i.e., internship, residency, etc.) in combination with formal coursework ( i.e., Tests and Measurement, Individual Assessment, or equivalent) qualifies a health care provider to purchase certain restricted products. Any PAR Customer already qualified to purchase a "B" or "C" level product, is also qualified to purchase an "S" level product. If you are not already qualified to purchase a "B"or "C" level product from PAR, please download and complete the special Qualification Form for Medical and Allied Health Professionals. (You will need Adobe Acrobat to view.) Close

The Cognistat is designed to rapidly assess neurocognitive functioning in three general areas: level of consciousness, orientation, and attention span; and five major ability areas: language, constructional ability, memory, calculation skills, and reasoning/ judgment.

Features and benefits

  • Includes a detailed and expanded discussion of the importance of individual “trait” factors and situational-environmental “state” factors that can affect test performance.
  • Provides an outline of commonly used medications that have the potential to affect test performance and a survey of 12 medical factors that frequently invalidate test results.
  • Offers a clear and immediately understandable graphic profile of impairments.
  • Includes normative information for adolescent, adult, and geriatric populations.
  • Provides documentation of the Cognistat’s utility in patients with dementia, stroke, traumatic brain injury, substance abuse, and epilepsy, citing a number of new clinical and research articles.
© 2000- by PAR, Inc., privately owned and operated since 1978. All rights reserved (2019-N). | Legal & Privacy Page | Manage Cookies